Evaluating Chicago's Success in Reaching the Healthy People 2000 Goal of Reducing Health Disparities

Abstract

Objective.

This study was designed to assess Chicago's progress from 1980 to 1998 in addressing the Healthy People 2000 goal of reducing health disparities.

Methods.

Chicago vital statistics and surveillance data were used to calculate black:white rate ratios of mortality and morbidity for 1980–1998. Mortality and morbidity rate ratios were also used to compare people living in areas with the lowest median household income with those living in the highest for 1979–1981, 1991–1993, and 1996–1998. The health measures included mortality associated with leading causes of death; all-cause mortality, incidence rates for two communicable diseases; and two birth outcomes.

Results.

Both black:white and low-income:high-income rate ratios monotonically increased for virtually all measures of mortality and morbidity. Almost all of the rate ratios and linear trends were statistically significant. From 1980 to 1998, the black:white rate ratio for all-cause mortality increased by 57% to 2.03. From 1979–1981 to 1996–1998, the low-income:high-income rate ratio for all-cause mortality increased by 56% to 2.68.

Conclusions.

These findings provide clear evidence that disparities in health did not decrease in Chicago. Instead, racial and economic disparities increased for almost all measures of mortality and morbidity used in this study. The fact that the Healthy People 2000 campaign to reduce and then eliminate health disparities was not effective must serve as a stimulus for improved strategies.

References

Ren

Amick

. Racial and ethnic disparities in self-assessed health status: evidence from the National Survey of Families and Households. Ethn Health 1996;1:293–303.

Mason

. Understanding the disparities in morbidity and mortality among racial and ethnic groups in the United States. Ann Epidemiol 1993;3:120–4.

Moss

. Socioeconomic disparities in health in the US: an agenda for action. Soc Sci Med 2000;51:1627–38.

Effective interventions for reducing racial and ethnic disparities in health. Am J Public Health 2001;91:485–6.

Mansfield

Kirk

Curry

Bobbitt-Cooke

. The challenge of eliminating health disparities in North Carolina. N C Med J 2001;62:19–25.

Bruechner

. Health disparities among racial and ethnic groups in Rhode Island. Med Health R I 2000;83:257–8.

Department of Health and Human Services (US). Eliminating racial and ethnic disparities in health: response to the Presidential Initiative on Race [reprint]. Public Health Rep 1998;113:372–5.

Department of Health and Human Services (US). Healthy people 2010: understanding and improving health. Washington: DHHS; 2000.

National Center for Health Statistics (US). Health, United States, 1998 with socioeconomic status and health chartbook. Hyattsville (MD): NCHS; 1998.

10.

Walker

Figgs

Zahm

. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 1995;103:275–81.

11.

Ng-Mak

Dohrenwend

Abraido-Lanza

Turner

. A further analysis of race differences in the National Longitudinal Mortality Study. Am J Public Health 1999;89:1748–51.

12.

Smith

Neaton

Wentworth

Stamler

. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet 1998;351:934–9.

13.

McNamara

. Racial disparities in health: a sociological analysis. J S C Med Assoc 1999;95:95–8.

14.

Williams

. Race, socioeconomic status, and health: the added effects of racism and discrimination. Ann N Y Acad Sci 1999;896:173–88.

15.

Williams

. Race and health: trends and policy implications. In: Auerbach

Krimgold

, editors. Income, status, socioeconomic status, and health. Washington: National Policy Association; 2001. p. 67–85.

16.

Williams

Collins

. US socioeconomic and racial differences in health. Annu Rev Sociol 1995;21:349–86.

17.

Pappas

Queen

Wilbur

Fisher

. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 1993;329:103–9.

18.

Geronimus

Bound

Waidmann

Hillemeier

Burns

. Excess mortality among blacks and whites in the United States. N Engl J Med 1996;355:1552–8.

19.

Geronimus

. Poverty, time, and place: variation in excess mortality across selected US populations, 1980–1990. J Epidemiol Community Health 1999;53:325–34.

20.

Polednak

. Black-white differences in sentinel causes of death: counties in large metropolitan areas. J Urban Health 2000;77:501–7.

21.

Polednak

. Mortality in Hartford, Connecticut: a comparison with the South Bronx, New York. J Urban Health 1998;75:550–7.

22.

McCord

Freeman

. Excess mortality in Harlem. N Engl J Med 1990;322:173–7.

23.

Chicago Department of Public Health. Community area health inventory. Vol. 1: Demographic and health profiles. Chicago: The Department; 1994 Oct.

24.

National Center for Health Statistics (US). Health, United States, 1996. National Vital Statistics Report Vol. 48, No. 11. Hyattsville (MD): NCHS; 1996.

25.

Chicago Department of Public Health. Community area health inventory, 1996–1998. Vol. 1: Demographic and health profiles. Chicago: The Department; 2000 May.

26.

Kleinbaum

Kupper

Morgenstern

. Epidemiologic research: principles and quantitative methods. Belmont (CA): Lifetime Learning Publications; 1982.

27.

Lantz

House

Lepkowski

Williams

Mero

Chen

. Socioeconomic factors, health behaviors, and mortality. JAMA 1998;279:1703–8.

28.

Cooper

David

. The biological concept of race and its application in public health and epidemiology. J Health Polit Policy Law 1986;11:97–116.

29.

Cooper

. Health and social status of blacks in the United States. Ann Epidemiol 1993;3:137–44.

30.

Krieger

Williams

Moss

. Measuring social class in US public health research. Annu Rev Public Health 1997;18:341–78.

31.

Krieger

Fee

. Social class: the missing link in U.S. health data. Int J Health Serv 1994;24:25–44.

32.

Allen

. The invention of the white race. New York: Verso Press; 1994.

33.

Ignatiev

. How the Irish became white. New York: Rotheledge Press; 1995.

34.

Bennett

. Before the Mayflower: a history of black America. New York: Penguin USA; 1993.

35.

Link

Phelan

. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;80–94.

36.

Sorlie

Backlund

, and Keller

. US mortality by economic, demographic, and social characteristics: the national longitudinal study. Am J Public Health 1995;85:949–56.

37.

Krieger

Rowley

Herman

Avery

Phillips

. Racism, sexism, and social class: implications for studies of heath, disease, and well being. Am J Prev Med 1993;9:82–122.

38.

Ren

Amick

Williams

. Racial/ethnic disparities in health: the interplay between discrimination and socioeconomic status. Ethn Dis 1999;9:151–65.

39.

Collins

. Racism and health: segregation and causes of death amenable to medical intervention in major U.S. cities. Ann N Y Acad Sci 1999;896:396–8.

40.

Williams

. Racism and health: a research agenda. Ethn Dis 1996;6:1–6.

41.

Polednack

. Segregation, discrimination, and mortality in U.S. blacks. Ethn Dis 1996;6:99–108.

42.

Susser

. The logic in ecological: I: the logic of analysis. Am J Public Health 1994;84:825–9.

43.

Gueyffier

Froment

Gouton

. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996;10:1–8.

44.

Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of people. BMJ 1994;305;81–106.

45.

Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998;351:30–42.

46.

Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451–67.

47.

Cohen

Fauci

. Current strategies in the treatment of HIV infection. Adv Intern Med 2001;46:207–46.

48.

Dutcher

Novik

O'Boyle

Marcoullis

Secco

Wiernik

. 20th-century advances in drug therapy in oncology. Part I. J Clin Pharmacol 2000;40:1007–24.

49.

Sakamoto

Takeda

Nakabayashi

. Advances in perinatal medical care—from our experience. Int J Gynaecol Obstet 1998;63:S107–14.

50.

Kaplan

Lynch

. Is economic policy health policy? Am J Public Health 2001;91:351–3.

51.

Geronimus

. To mitigate, resist, or undo: addressing structural influences on the health of urban populations. Am J Public Health 2000;90:867–72.

52.

Cohen

Northridge

. Getting political: racism and urban health. Am J Public Health 2000;90:841–2.